Genomic alterations are common in metastatic castration-resistant prostate cancer (mCRPC), but limited data exist on the response to 177Lu-PSMA-617 (LuPSMA) in patients with these aberrations. We ...

The aim of this work was to develop a theranostic method that allows prediction of prostate-specific membrane antigen (PSMA)–positive tumor volume after radioligand therapy (RLT) based on a ...

Update to “Renal and Multiorgan Safety of 177 Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy” ...

Objectives The aim of our study was to compare two methods for SUVr calculations in amyloid PET brain imaging. Methods In a continuing study, 19 patients were imaged on a GE STE 16 slice PET/CT system ...

Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...

Journal of Nuclear Medicine May 2024, jnumed.124.267417; DOI: https://doi.org/10.2967/jnumed.124.267417 ...

Upregulation of tissue factor (TF) expression leads to increased patient morbidity and mortality in many solid tumor types. The goal of this study was to develop a PET tracer for imaging of TF ...

Journal of Nuclear Medicine December 2023, jnumed.123.266741; DOI: https://doi.org/10.2967/jnumed.123.266741 ...

Gastrin-releasing peptide (GRP) receptors (GRPr) are frequently overexpressed in human prostate cancer, and radiolabeled GRPr affinity ligands have shown promise for in vivo imaging of prostate cancer ...

Previous studies on the utility of specific perfusion patterns in ictal brain perfusion SPECT for predicting the outcome of temporal lobe epilepsy surgery used qualitative visual pattern ...

Introduction: Carbonic anhydrase IX (CAIX) is highly expressed in hypoxic tumors, where it plays a key role in maintaining the acidic tumor microenvironment, closely linked to tumor progression, ...

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...